The overexpression of cIAP1 in bladder cancer, cervical cancer, and head and neck tumors indicates a poor prognosis, while the overexpression of cIAP2 is a biomarker for the early advanced stage of pancreatic cancer [21–23]. Here, BIRC2 is linked to cervical cancer.